Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
Clinical trial NCT06165341 · RECRUITING
Trial details
- NCT number
- NCT06165341
- Sponsor
- Takeda
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2028-08-26
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.